Hagar Merav Shamir

Hagar Merav Shamir

Auto-generated profile, based on publicly available information

Hagar Merav Shamir

Veterinary Teaching Hospital, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2019 in Epilepsia
Verified
Journal Article
Closed access
PDF file
EHErez Hanael
Erez Hanael
RVRonel Veksler
Ronel Veksler
AFAlon Friedman
Alon Friedman
GBGuy Bar‐Klein
Guy Bar‐Klein
VSVladimir V. Senatorov
Vladimir V. Senatorov
MSMerav H. Shamir
Merav H. Shamir

28 August 2008 in Veterinary Radiology & Ultrasound
Verified
Journal Article
Closed access
PDF file
OCOrit Chai
Orit Chai
ISIlan Shelef
Ilan Shelef
OBOri Brenner
Ori Brenner
ODOsnat Dogadkin
Osnat Dogadkin
IAItamar Aroch
Itamar Aroch
MSMerav H. Shamir
Merav H. Shamir

1 March 2022 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
EHErez Hanael
Erez Hanael
SBShelly Baruch
Shelly Baruch
OCOrit Chai
Orit Chai
ZNZohar Nir
Zohar Nir
KRKira Rapoport
Kira Rapoport
MSMerav H. Shamir
Merav H. Shamir
Background: The blood-brain barrier (BBB), which separates the intravascular and neuropil compartments, characterizes the vascular bed of the brain and is essential for its proper function. Recent advances in imaging techniques have driven the development of methods for quantitative assessment of BBB permeability. Hypothesis/Objectives: Permeability of the BBB can be assessed quantitatively in dogs with meningoencephalitis of unknown origin (MUO) and its status is associated with the occurrence of seizures. Animals: Forty dogs with MUO and 12 dogs without MUO. Methods: Retrospective, prospective cohort study. Both dynamic contrast enhancement (DCE) and subtraction enhancement analysis (SEA) methods were used to evaluate of BBB permeability in affected (DCE, n = 8; SEA, n = 32) and control dogs (DCE, n = 6; SEA, n = 6). Association between BBB dysfunction (BBBD) score and clinical characteristics was examined. In brain regions where BBBD was identified by DCE or SEA magnetic resonance imaging (MRI) analysis, immunofluorescent staining for albumin, glial fibrillary acidic protein, ionized calcium binding adaptor molecule, and phosphorylated mothers against decapentaplegic homolog 2 were performed to detect albumin extravasation, reactive astrocytes, activated microglia, and transforming growth factor beta signaling, respectively. Results: Dogs with BBBD had significantly higher seizure prevalence (72% vs 19%; P = .01) when compared to MUO dogs with no BBBD. The addition of SEA to routine MRI evaluation increased the identification rate of brain pathology in dogs with MUO from 50% to 72%. Conclusions and Clinical Importance: Imaging-based assessment of BBB integrity has the potential to predict risk of seizures in dogs with MUO.

1 June 2015 in Research in Veterinary Science
Verified
Journal Article
Closed access
YCY. Chamisha
Y. Chamisha
IAI. Aroch
I. Aroch
SKS. Kuzi
S. Kuzi
ISI. Srugo
I. Srugo
TBT. Bdolah-Abram
T. Bdolah-Abram
MSM.H. Shamir
M.H. Shamir

1 March 2023 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
PDF file
NANimrod Asiag
Nimrod Asiag
OCOrit Chai
Orit Chai
SYSapir Yodovner
Sapir Yodovner
MRMarco Ruggeri
Marco Ruggeri
KRKira Rapaport
Kira Rapaport
MSMerav H. Shamir
Merav H. Shamir
OBJECTIVE: To evaluate the efficiency and safety of a doramectin-based treatment protocol in dogs affected by intraspinal spirocercosis (Spirocerca lupi). ANIMALS: Client-owned dogs that were admitted to a veterinary hospital during 2021 to 2022 with acute onset of neurological signs and diagnosed with intraspinal spirocercosis. All dogs underwent complete neurological evaluation, CSF analysis, PCR confirmation of CNS S lupi infection, and follow-up evaluation of at least 6 months. PROCEDURES: Upon diagnosis, dogs were treated with doramectin at a dose of 400 μg/kg, SC, q 24 h for 3 consecutive days, followed by the same dose once a week for 6 weeks. Prednisone was administered at a dose of 1 mg/kg, PO, q 24 h and tapered every 3 days. Antimicrobial clindamycin was administered at a dose of 12.5 mg/kg, PO, q 12 h for 7 days to reduce the risk of secondary spinal cord infection. Short- and long-term outcomes (1 week to 56 months) were recorded. RESULTS: 8 dogs fulfilled the inclusion criteria, 7 of which presented with neurological deficits and 1 with cervical pain. Initiation of treatment was associated with stopping the deterioration in 7 of 8 dogs. Seven dogs improved and 6 recovered ambulation. One dog was euthanized due to lack of improvement. Six of the recovered dogs were still ataxic on the last follow-up examination at 6 to 56 months. No adverse effects of the drug were noted. CLINICAL RELEVANCE: Frequent administration of doramectin was found to be safe and effective in preventing neurological deterioration in dogs with intraspinal spirocercosis.

22 April 2022 in Journal of Veterinary Diagnostic Investigation
Verified
Journal Article
Closed access
NANimrod Asiag
Nimrod Asiag
RLRoi Lapid
Roi Lapid
ZAZahi Aizenberg
Zahi Aizenberg
GBGad Baneth
Gad Baneth
YNYaarit Nachum-Biala
Yaarit Nachum-Biala
MSMerav H. Shamir
Merav H. Shamir
Protothecosis, an infectious disease caused by the green algae Prototheca zopfii and P. wickerhamii, occurs sporadically in domestic animals and humans. Diagnosis of CNS protothecosis is based on neurologic signs that indicate multifocal nervous system lesions and that follow a period of chronic diarrhea and weight loss, cytologic observation of algae in fecal culture or histopathology, and detection of the agent by PCR assay of infected tissues. Here, we report a case of a paraparetic dog with CNS protothecosis that was diagnosed definitively antemortem using CSF cytology, PCR, and DNA sequencing. A 4-y-old mixed-breed dog developed progressive paraparesis that followed weight loss and diarrhea. CSF analysis revealed marked eosinophilic pleocytosis. Prototheca organisms were detected by microscopic examination of the CSF, and speciated as P. zopfii by CSF PCR and DNA sequencing. Other possible causes of paraparesis were ruled out using computed tomography, serology, and CSF PCR. The dog’s condition deteriorated despite treatment, developing forebrain and central vestibular system clinical signs, and it was euthanized at the owner’s request. Postmortem examination was declined. Our findings indicate that when CNS protothecosis is suspected, antemortem diagnosis can be made using CSF analysis and a PCR assay.